id: sphingolipid_dysregulation_to_ischemic_heart_disease
name: Sphingolipid Dysregulation → Ischemic Heart Disease
from_node:
  node_id: sphingolipid_dysregulation
  node_name: Sphingolipid Dysregulation
to_node:
  node_id: ischemic_heart_disease
  node_name: Ischemic Heart Disease
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Disruption of normal sphingolipid metabolism leads to altered levels of
  biologically active sphingolipid compounds in cardiac tissue'
- 'Step 2: Dysregulated sphingolipid signaling affects cellular processes including
  proliferation, maturation, and cell death in cardiovascular tissues'
- 'Step 3: These pathological cellular changes contribute to the development and progression
  of ischemic heart disease pathophysiology'
evidence:
  quality_rating: C
  n_studies: null
  primary_citation: S. Borodzicz-Jażdżyk et al. 2022. "Sphingolipid metabolism and
    signaling in cardiovascular diseases." *Frontiers in Cardiovascular Medicine*.
    https://doi.org/10.3389/fcvm.2022.915961
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.445740'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
